ACLY and cancer: ACLY cleaves citrate into oxaloacetate and acetyl-CoA, ACLY is essential for tumorigenesis in mouse cancer models, and its compound inhibitors with high IC50 values have antitumor efficacy in xenograft models of lung and prostate cancer.